People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 180 Life Sciences Corp. | — | Other | Growth/Late | $454.6M | $4.2B | 2021 |
| Viracta Therapeutics, INC. | — | Biotechnology | Series C | $164.6M | $2.1B | 2010 |
| Neuraltus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $40.6M | $462.7M | 2009 |
James N. Woody at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James N. Woody on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Woody | 2 | 4 |
| John Walker | 1 | 17 |
| Patrick Soon-Shiong | 1 | 16 |
| Ryan Smith | 1 | 11 |
| Ivor Royston | 1 | 7 |
| Terry Gould | 1 | 6 |
| Annette Bianchi | 1 | 4 |
| Lawrence Steinman | 1 | 4 |
| Roger Pomerantz | 1 | 4 |
| Paul Goddard | 1 | 4 |
| Barry Simon | 1 | 3 |
| Armen Shanafelt | 1 | 3 |
| Frederick Dotzler | 1 | 3 |
| Ronald Berenson | 1 | 3 |
| Blair Jordan | 1 | 3 |
| Ari Azhir | 1 | 3 |
| Wayne Roe | 1 | 2 |
| Stephen Shoemaker | 1 | 2 |
| John Whelan | 1 | 2 |
| Gur Roshwalb | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.